米达佐拉姆对癌症进展/生存的作用 - - 更新的系统性审查
Ansh Sethi1, Amal Rezk2, Rachel Couban3
1Faculty of Science, McMaster University, Hamilton, ON, Canada.
Indian journal of anaesthesia
|January 12, 2024
概括
米达佐拉姆在延缓癌症进展和减少癌细胞存活率方面表现有前途. 需要进一步的研究来探索其作为人类临床试验中的抗癌剂的潜力.
科学领域:
- 瘤学和药理学方面的研究.
- 癌症研究 癌症研究
- 药物发现 药物发现 药物发现
背景情况:
- 癌症仍然是一个重大的全球健康挑战,推动了对新型治疗策略的需求.
- 作为常见的麻醉剂辅助剂的米达佐兰正在研究其潜在的抗癌性质.
- 弥达佐拉姆潜在的抗癌作用背后的精确机制需要进行彻底的研究.
研究的目的:
- 系统地审查现有的临床前证据,以评估米达佐拉姆对癌症进展和生存的影响.
- 综合了体外和体内研究的研究结果,研究米达佐拉姆对各种癌症类型的影响.
主要方法:
- 系统的文献搜索,遵循系统审查和元分析 (PRISMA) 准则的首选报告项目.
- 包括临床前研究 (体外和体内) 检查米达佐拉姆对癌症的影响.
- 从2022年11月之前发表的符合条件的研究中对数据进行叙述综合和定量分析.
主要成果:
- 在19项纳入的研究中,米达佐拉姆通过延缓癌症进展在89%的患者中表现出抗癌作用,并在63%的患者中通过减少癌症细胞存活率来表现出抗癌作用.
- 关键机制包括诱导亡 (63%) 和抑制癌细胞增殖 (53%).
- 还观察到抗转移性质,例如抑制入侵和迁移.
结论:
- 米达佐拉姆具有作为一种阻碍癌症进展和增强癌症细胞死亡的药物的潜力.
- 这些临床前发现需要进一步调查,以确定米达佐拉姆在人类癌症治疗中的有效性和安全性.
相关概念视频
01:21Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
205
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
205
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
292
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
292
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K